By Anne-Marie Tasker and Chloé Laversuch Health Correspondent, BBC Look North November 13, 2023 Image source, Anne-Marie Tasker Legend, Nicolle called for the drug Kaftrio, which could be used to treat her baby daughter Charlie, not to be withdrawn. The mother of a baby born with cystic fibrosis has urged… Continue Reading Mum pleads for NHS drug to extend baby’s life – BBC News
OLATHE, Kan. A new, first-of-its-kind oral pill to treat postpartum depression, which affects 1 in 7 women, comes with a hefty price tag. The U.S. Food and Drug Administration approved Zurzuvae in August, but the company that makes the drug just announced the shocking price this week: $15,900 before insurance.… Continue Reading New Postpartum Depression Drug Costs Nearly $16,000
AstraZeneca is the latest player to enter the weight-loss drug space, a market that some analysts say could reach $100 billion by 2030. On Thursday, the biopharmaceutical company announced it had entered into a licensing agreement with Eccogene for ECC5004 , an oral glucagon-like peptide 1 receptor agonist. This drug,… Continue Reading There’s a new entry into the weight-loss drug boom. Here’s the stock’s outlook
The Food and Drug Administration on Wednesday has approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that in clinical trials has been shown to help people lose up to 52 pounds in 16 months. Related to Zep is the latest entrant in the field of powerful new… Continue Reading FDA approves Eli Lillys Zepbound, a weight loss drug similar to Ozempic and Wegovy
The Food and Drug Administration on Wednesday has approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that in clinical trials has been shown to help people lose up to 52 pounds in 16 months. Related to Zep is the latest entrant in the field of powerful new… Continue Reading FDA Approves Eli Lilly’s Weight Loss Drug That Helped People Lose Up to 52 Pounds
TEMPSOFINDIA.COM | Last updated on – November 8, 2023, 6:00 PM IST A 56-year-old Australian woman wanted to lose weight for her daughter’s wedding; deceased Trish Webster, a 56-year-old Australian woman, died from gastrointestinal illness caused by the drug Ozempic. Today, her husband warns that the drug is “not worth… Continue Reading Weight loss: Woman dies from side effects of popular weight loss drug, Ozempic
A proposed class action lawsuit has been filed in the British Columbia Supreme Court, alleging that the Canadian manufacturer of Ozempic failed to warn potential patients of possible complications. This medication has exploded in popularity since doctors began prescribing it for weight loss. But Tracy Nygaard, 54, was taking Ozempic… Continue Reading Proposed class action lawsuit filed against Canadian maker of popular weight loss drug Ozempic
Health experts in Poland have issued recommendations to the government calling for specific measures to increase drug safety and boost domestic production. Medicine safety encompasses the entire journey of pharmaceutical products, from production facilities to the hands of patients in pharmacies and hospitals. This goes beyond just manufacturing medicines, as… Continue Reading Experts call for overhaul of pharmaceutical policies to ensure drug safety
President Biden’s war on drug prices is a solution to shortages and dwindling numbers of new and innovative medicines. To make matters worse, he continues to brag about his populist reforms as if they will solve the problems with our health care system, the economy, itches, stitches, paralysis and gout.… Continue Reading The problem of controlling drug prices
Medicine By Marc Lallanilla Published October 26, 2023, 3:45 p.m. ET For people suffering from a COVID-19 attack, the antiviral Paxlovid has been a godsend. The drug became the go-to antiviral treatment during the pandemic after the Food and Drug Administration granted it emergency use authorization in December 2021. Now… Continue Reading Why COVID sufferers in the US can’t get ensitrelvir, the antiviral drug better than Paxlovid